Fine-Tuning of Awake Prefrontal Cortex Neurons by Clozapine: Comparison With Haloperidol and N-Desmethylclozapine

Houman Homayoun, Bita Moghaddam

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: Mechanisms underlying clozapine's better clinical efficacy in schizophrenia remain poorly understood. The prefrontal cortex (PFC) has been implicated as a primary site for the therapeutic effects of clozapine; however, evidence for how clozapine influences the activity of PFC neurons in behaviorally relevant contexts is lacking. Methods: Ensemble single unit recording in awake rats was used to measure the activity of PFC neurons in response to clozapine, its main metabolite N-desmethylclozapine (DMClz), and the typical antipsychotic drug haloperidol during baseline conditions and after treatment with the N-methyl-D-aspartate antagonist MK801. Behavioral stereotypy was scored during recording. Results: Clozapine and DMClz but not haloperidol had an activity-dependent influence on spontaneous firing rate of PFC cells: they increased the activity of neurons with low baseline firing rates and decreased the activity of neurons with higher firing rates. Clozapine and DMClz but not haloperidol also reversed the effect of MK801 on PFC neuronal firing. This reversal was strongly correlated with blockade of MK801-induced behavioral stereotypy. Conclusions: These findings indicate that clozapine has the capacity to fine-tune spontaneous and disrupted activity of PFC neurons. This effect might contribute, in part, to the therapeutic efficacy of clozapine in schizophrenia.

Original languageEnglish (US)
Pages (from-to)679-687
Number of pages9
JournalBiological Psychiatry
Volume61
Issue number5
DOIs
StatePublished - Mar 1 2007
Externally publishedYes

Fingerprint

norclozapine
Clozapine
Haloperidol
Prefrontal Cortex
Neurons
Schizophrenia
Therapeutic Uses
N-Methylaspartate

Keywords

  • Atypical antipsychotic drugs
  • cognition
  • dopamine
  • ensemble unit electrophysiology
  • NMDA receptor antagonist
  • schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Fine-Tuning of Awake Prefrontal Cortex Neurons by Clozapine : Comparison With Haloperidol and N-Desmethylclozapine. / Homayoun, Houman; Moghaddam, Bita.

In: Biological Psychiatry, Vol. 61, No. 5, 01.03.2007, p. 679-687.

Research output: Contribution to journalArticle

@article{1d00f59279574913a430ce87f7ad5a12,
title = "Fine-Tuning of Awake Prefrontal Cortex Neurons by Clozapine: Comparison With Haloperidol and N-Desmethylclozapine",
abstract = "Background: Mechanisms underlying clozapine's better clinical efficacy in schizophrenia remain poorly understood. The prefrontal cortex (PFC) has been implicated as a primary site for the therapeutic effects of clozapine; however, evidence for how clozapine influences the activity of PFC neurons in behaviorally relevant contexts is lacking. Methods: Ensemble single unit recording in awake rats was used to measure the activity of PFC neurons in response to clozapine, its main metabolite N-desmethylclozapine (DMClz), and the typical antipsychotic drug haloperidol during baseline conditions and after treatment with the N-methyl-D-aspartate antagonist MK801. Behavioral stereotypy was scored during recording. Results: Clozapine and DMClz but not haloperidol had an activity-dependent influence on spontaneous firing rate of PFC cells: they increased the activity of neurons with low baseline firing rates and decreased the activity of neurons with higher firing rates. Clozapine and DMClz but not haloperidol also reversed the effect of MK801 on PFC neuronal firing. This reversal was strongly correlated with blockade of MK801-induced behavioral stereotypy. Conclusions: These findings indicate that clozapine has the capacity to fine-tune spontaneous and disrupted activity of PFC neurons. This effect might contribute, in part, to the therapeutic efficacy of clozapine in schizophrenia.",
keywords = "Atypical antipsychotic drugs, cognition, dopamine, ensemble unit electrophysiology, NMDA receptor antagonist, schizophrenia",
author = "Houman Homayoun and Bita Moghaddam",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.biopsych.2006.05.016",
language = "English (US)",
volume = "61",
pages = "679--687",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Fine-Tuning of Awake Prefrontal Cortex Neurons by Clozapine

T2 - Comparison With Haloperidol and N-Desmethylclozapine

AU - Homayoun, Houman

AU - Moghaddam, Bita

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Background: Mechanisms underlying clozapine's better clinical efficacy in schizophrenia remain poorly understood. The prefrontal cortex (PFC) has been implicated as a primary site for the therapeutic effects of clozapine; however, evidence for how clozapine influences the activity of PFC neurons in behaviorally relevant contexts is lacking. Methods: Ensemble single unit recording in awake rats was used to measure the activity of PFC neurons in response to clozapine, its main metabolite N-desmethylclozapine (DMClz), and the typical antipsychotic drug haloperidol during baseline conditions and after treatment with the N-methyl-D-aspartate antagonist MK801. Behavioral stereotypy was scored during recording. Results: Clozapine and DMClz but not haloperidol had an activity-dependent influence on spontaneous firing rate of PFC cells: they increased the activity of neurons with low baseline firing rates and decreased the activity of neurons with higher firing rates. Clozapine and DMClz but not haloperidol also reversed the effect of MK801 on PFC neuronal firing. This reversal was strongly correlated with blockade of MK801-induced behavioral stereotypy. Conclusions: These findings indicate that clozapine has the capacity to fine-tune spontaneous and disrupted activity of PFC neurons. This effect might contribute, in part, to the therapeutic efficacy of clozapine in schizophrenia.

AB - Background: Mechanisms underlying clozapine's better clinical efficacy in schizophrenia remain poorly understood. The prefrontal cortex (PFC) has been implicated as a primary site for the therapeutic effects of clozapine; however, evidence for how clozapine influences the activity of PFC neurons in behaviorally relevant contexts is lacking. Methods: Ensemble single unit recording in awake rats was used to measure the activity of PFC neurons in response to clozapine, its main metabolite N-desmethylclozapine (DMClz), and the typical antipsychotic drug haloperidol during baseline conditions and after treatment with the N-methyl-D-aspartate antagonist MK801. Behavioral stereotypy was scored during recording. Results: Clozapine and DMClz but not haloperidol had an activity-dependent influence on spontaneous firing rate of PFC cells: they increased the activity of neurons with low baseline firing rates and decreased the activity of neurons with higher firing rates. Clozapine and DMClz but not haloperidol also reversed the effect of MK801 on PFC neuronal firing. This reversal was strongly correlated with blockade of MK801-induced behavioral stereotypy. Conclusions: These findings indicate that clozapine has the capacity to fine-tune spontaneous and disrupted activity of PFC neurons. This effect might contribute, in part, to the therapeutic efficacy of clozapine in schizophrenia.

KW - Atypical antipsychotic drugs

KW - cognition

KW - dopamine

KW - ensemble unit electrophysiology

KW - NMDA receptor antagonist

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=33847289217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847289217&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2006.05.016

DO - 10.1016/j.biopsych.2006.05.016

M3 - Article

C2 - 17046721

AN - SCOPUS:33847289217

VL - 61

SP - 679

EP - 687

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 5

ER -